Canadian Federal Court set to fast-track patent cases
15 September 2008
Eileen McDermott, New York
A case between two major Canadian pharmaceutical companies could signal change for the way patent cases are tried in the country
In July this year, Servier Canada secured a victory over the largest Canadian-owned pharmaceutical company, Apotex, which Servier claimed had infringed its Canadian patent, number 1,341,196 (the ’196 patent) for the hypertension drug, perindopril.
Servier claimed that Apotex had been infringing its patent since 2006 by manufacturing and selling a generic version of the drug, and that it also had induced other parties to infringe the patent. Apotex filed counterclaims against Servier, arguing that the ‘196 patent was invalid and that Servier violated the...
Only subscribers have complete access to Managing IP Magazine,
log in or
subscribe now.
Alternatively take a
free trial, giving you 48-hour access to Managing IP Magazine (some articles and surveys may be excluded).
Subscribe Now
This article is available to subscribers. Please click subscribe to read the rest of the article.
Subscribe
Take a free trial
Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.
Take a free trial